Cocrystal Pharma, Inc. (COCP) Earnings History
Annual and quarterly earnings data from 2007 to 2024
Loading earnings history...
COCP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
COCP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | -199.6% | -476.0% | -479.0% |
Download Data
Export COCP earnings history in CSV or JSON format
Free sign-in required to download data
Cocrystal Pharma, Inc. (COCP) Earnings Overview
As of May 8, 2026, Cocrystal Pharma, Inc. (COCP) reported trailing twelve-month net income of -$10M. The company earned $-0.88 per diluted share over the past four quarters.
Looking at the long-term picture, COCP's historical earnings data spans multiple years. The company achieved its highest annual net income of -$41,370 in fiscal 2009.
Cocrystal Pharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including AGEN ($115,000 net income, 0.1% margin), ABUS (-$34M net income, -237.9% margin), RDVT ($14M net income, 14.6% margin), COCP has comparable earnings metrics. Compare COCP vs AGEN →
COCP Earnings vs Peers
Earnings metrics vs comparable public companies
COCP Historical Earnings Data (2007–2024)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$18M | +2.7% | -$18M | $-1.72 | - | - |
| 2023 | -$18M | +53.7% | -$19M | $-0.00 | - | - |
| 2022 | -$39M | -173.8% | -$39M | $-4.77 | - | - |
| 2021 | -$14M | -47.0% | -$14M | $-1.85 | - | - |
| 2020 | -$10M | +80.0% | -$10M | $-2.01 | -479.0% | -476.0% |
| 2019 | -$48M | +1.8% | -$48M | $-15.78 | -733.8% | -737.4% |
| 2018 | -$49M | -7901.3% | -$63M | $-21.01 | - | - |
| 2017 | $-613,000 | +99.2% | -$8M | $-0.30 | - | - |
| 2016 | -$75M | -49.4% | -$106M | $-38.14 | - | - |
| 2015 | -$50M | -50528.3% | -$54M | $-28.60 | -64259.0% | -69164.1% |
See COCP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs COCP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare COCP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCOCP — Frequently Asked Questions
Quick answers to the most common questions about buying COCP stock.
Is COCP growing earnings?
COCP TTM EPS: $-0.88. Net income: $-10M. Earnings growth: N/A.
What are COCP's profit margins?
Cocrystal Pharma, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are COCP's earnings?
COCP earnings data spans 2007-2024. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.